These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1188181)

  • 21. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
    McDonnell PA; Caldwell GW; Masucci JA
    Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum.
    Yosselson-Superstine S; Yanuka Y; Ishai S
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):181-6. PubMed ID: 7076348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of furosemide to albumin isolated from human fetal and adult serum.
    Viani A; Cappiello M; Silvestri D; Pacifici GM
    Dev Pharmacol Ther; 1991; 16(1):33-40. PubMed ID: 1879250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
    Brodersen R; Jørgensen N; Vorum H; Krukow N
    Mol Pharmacol; 1990 May; 37(5):704-9. PubMed ID: 2111005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems I. Investigation of propofol binding in model HSA solution.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 May; 34(1):30-6. PubMed ID: 18374549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

  • 30. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.
    Kates RE; Sokoloski TD; Comstock TJ
    Clin Pharmacol Ther; 1978 Jan; 23(1):30-5. PubMed ID: 618708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.
    Nilsen OG; Fremstad D; Jacobsen S
    Eur J Pharmacol; 1975 Aug; 33(1):131-9. PubMed ID: 1175679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
    Perez-Mateo M; Erill S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method of computing the distribution of a ligand among multiple binding sites on different proteins in plasma: thyroxine as an illustrative example.
    Wosilait WD; Nagy P
    Comput Programs Biomed; 1976 Dec; 6(4):232-37. PubMed ID: 827417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative models for the analysis of drug-protein binding.
    Fletcher JE; Spector AA
    Mol Pharmacol; 1977 May; 13(3):387-99. PubMed ID: 876031
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma binding of quinidine after surgery: a preliminary report.
    Fremstad D; Bergerud K; Haffner JF; Lunde PK
    Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
    Garfinkel D; Mamelok RD; Blaschke TF
    Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.